FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH
Risk factors for incident falls and fractures in older men with and without type 2 diabetes mellitus: the Concord Health and Ageing in Men Project
With around 15% of people failing to get the right levels of Vitamin B12 through their diet alone and with the body unable to produce any for itself, supplements and injections have become a common solution
Each GLP-1 medication has patient-specific dosing
Benefits Faster Tan With Less Sun Quicker colour with less time in direct sun, helping you reduce long, highintensity UV sessions
Higher risk groups include: People starting GLP-1 medicines for the first time People whose dose is increased too quickly People who eat large, oily, or very sweet meals People with type 2 diabetes using insulin or sulfonylureas People with previous pancreatitis People with gallstones or gallbladder disease People with severe digestive disorders People with gastroparesis People with kidney disease People with dehydration risk People with diabetic retinopathy People with a personal or family history of medullary thyroid carcinoma People with Multiple Endocrine Neoplasia syndrome type 2 People with active mood disorders or suicidal thoughts People planning surgery or procedures under anaesthesia Patients With Diabetes Vs Non-Diabetic Users People with diabetes may use GLP-1 medicines to improve blood sugar control and support weight management